Softwr

Healthcare · head to head

Annalise.ai vs Kareo

Annalise.ai logo

Annalise.ai

Healthcare

Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model

From
On request
Rated
-
Full reviewWebsite
Kareo logo

Kareo

Healthcare

Cloud-based EHR and billing for small practices

From
$99/month
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Annalise.ai the United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.; Kareo kareo is now part of Tebra and sold under the Tebra brand rather than as a standalone product
  • They diverge on capability: Annalise.ai covers Annalise Enterprise CXR, Kareo covers Electronic Health Records.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Annalise.ai and Kareo actually diverge.

Attributes where Annalise.ai and Kareo differ
AttributeAnnalise.aiKareo
Starting priceOn request$99/month
Pricing modelquotesubscription
PlatformsWeb, Cloud, On-premiseWeb, Mobile
FoundedUnknown2010

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Annalise.ai

  • Annalise Enterprise CXR
  • Annalise Enterprise CTB
  • Triage and notification
  • Worklist reprioritisation
  • Localisation overlays
  • Confidence output
  • PACS-native deployment
  • On-premise or cloud inference

Only in Kareo

  • Electronic Health Records
  • Scheduling
  • Patient Portal
  • Medical Billing
  • Payment Processing
  • Labs
  • Pharmacies
  • Clearinghouses

What people use each for

The jobs each tool is most often brought in to do.

Annalise.ai

  • An emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnestnot Kareo
  • A teleradiology provider covering many small hospitals that needs consistent triage before a human readsnot Kareo
  • A screening programme in Europe where the broader CE marked decision support indication, rather than the narrow United States triage clearance, is what is being deployednot Kareo
  • A radiology department building an AI governance programme that wants one vendor covering both chest radiograph and head CT rather than contracting two separate algorithm suppliersnot Kareo

Kareo

  • Practice management, scheduling and billing for independent medical practicesnot Annalise.ai
  • Electronic health records and e-prescribing for small clinicsnot Annalise.ai
  • Insurance claim submission and patient payment collectionnot Annalise.ai

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Annalise.ai

  • The United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.
  • Triage AI reprioritises a worklist but does not change clinical decisions on its own, so departments that do not redesign how urgent studies are picked up see no measurable improvement in time to treatment.
  • Published validation is largely reader study evidence on detection of individual findings; prospective evidence of shorter time to treatment in routine emergency care is thin.
  • The Annalise brand is being migrated under the Harrison.ai name for the critical care offering, which creates ambiguity in multi-year contracts about what product name is actually being supported.
  • A high finding count raises the alert burden, and departments report that low prevalence findings generate false positives that erode radiologist trust unless the alerting thresholds are tuned locally.

Kareo

  • Kareo is now part of Tebra and sold under the Tebra brand rather than as a standalone product
  • Tebra publishes no rate: pricing varies with provider count, features and implementation requirements and is quoted during a demo
  • Billing counts clinical providers such as MDs, DOs, NPs and PAs, so adding a prescriber raises the bill even though non clinical staff are free
  • Electronic prescribing of controlled substances setup costs about $75 per provider as a one time fee
  • PDMP integration costs $500 one time per facility plus about $50 per user per year

Pricing, plan by plan

Annalise.ai

On request
  • Annalise Enterprise$undefined/year
    • Priced per study analysed or as an annual volume subscription
    • CXR and CTB licensed separately
    • Cleared finding set differs by market, which changes what you are buying

Kareo

$99/month
  • Starter$99/month
    • EHR
    • Scheduling
    • Patient Portal
  • Professional$199/month
    • Everything in Starter
    • Billing
    • Reporting

Which should you pick?

Choose Annalise.ai if

  • You need annalise enterprise cxr.
  • You work on Web, Cloud, On-premise.
  • You also want annalise enterprise ctb.
Annalise.ai review

Choose Kareo if

  • You need electronic health records.
  • You work on Web, Mobile.
  • You also want scheduling.
Kareo review

Questions people ask

Is Annalise.ai or Kareo better?
Neither clearly leads. Annalise.ai starts at On request and Kareo at $99/month, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Annalise.ai or Kareo?
Annalise.ai starts at On request and Kareo at $99/month.
Does Annalise.ai or Kareo run on more platforms?
Annalise.ai runs on Web, Cloud, On-premise. Kareo runs on Web, Mobile.
What is Annalise.ai best used for?
Annalise.ai is most often used for an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest, a teleradiology provider covering many small hospitals that needs consistent triage before a human reads, a screening programme in europe where the broader ce marked decision support indication, rather than the narrow united states triage clearance, is what is being deployed, a radiology department building an ai governance programme that wants one vendor covering both chest radiograph and head ct rather than contracting two separate algorithm suppliers. Of those, an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest and a teleradiology provider covering many small hospitals that needs consistent triage before a human reads are not what Kareo is typically brought in for.
What can Annalise.ai do that Kareo cannot?
Annalise.ai covers Annalise Enterprise CXR, Annalise Enterprise CTB, Triage and notification, Worklist reprioritisation. Kareo covers Electronic Health Records, Scheduling, Patient Portal, Medical Billing.

Answered from the vendors’ own pages

Annalise.ai: How many findings are FDA cleared?

Around ten across chest X-ray and head CT, for triage and notification only. The model reports far more findings than that; the rest are not cleared in the United States.

Kareo: Does Kareo publish its pricing?

No. Kareo (now rebranded as Tebra) uses custom per-practice pricing that varies based on the number of providers, features needed, and implementation requirements. Pricing is determined during a demo with the sales team.

Source
Annalise.ai: Is the European position different?

Yes. CE marking under the medical device regulation covers a broader decision support indication than the United States triage and notification clearances, so the same software is a different regulatory product depending on where you deploy it.

Kareo: Are there discounts for adding multiple modules?

Yes. Tebra states that many practices qualify for bundled pricing or volume incentives when adopting multiple modules like EHR, billing, and patient experience tools together.

Source
Annalise.ai: Does it diagnose?

No. In the United States it is a triage and notification device: it flags studies for earlier review, and the radiologist makes the diagnosis.

Kareo: What are the additional costs for controlled substance prescribing?

For providers who prescribe controlled substances, EPCS setup costs approximately $75 per provider as a one-time fee, and PDMP integration costs $500 one-time per facility plus around $50 per user per year.

Source
Annalise.ai: Is Annalise.ai becoming Harrison.ai?

The critical care offering is now marketed under the Harrison.ai name. Ask the vendor to name the contracted product explicitly before signing a multi-year deal.

Kareo: Does Kareo offer a free trial?

Kareo's website does not mention a free trial option. Access to pricing and trial arrangements requires contacting the sales team to request a demo.

Source
Share

Related pages

More on Annalise.ai

More on Kareo

Keep looking

Other head to heads